MoneyWorks4Me

Bal Pharma informs about loss/reissue of duplicate share certificate

29 Dec 2022 Evaluate

Pursuant to Regulation 39(3) of SEBI(LODR) Regulations,2015, Bal Pharma has submitted to the exchange the intimation received from its R&T agents - TSR Consultants, Mumbai, regarding loss/reissue of duplicate share certificates by/to one of its shareholders.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1745.00
Dr. Reddys Labs. 1237.65
Cipla 1313.80
Lupin 1957.00
Zydus Lifesciences 1117.30
View more..